Rheumatoid arthritis patients who achieve low disease activity or remission may successfully taper their biologics, saving costs as a result, according to new research findings presented this week at the 2018 ACR/ARHP Annual Meeting.
A new DNA tool created by Michigan State University can accurately predict people’s height, and more importantly, could potentially assess their risk for serious illnesses, such as heart disease and cancer.
Scientists at the Krembil Research Institute have developed a novel therapeutic treatment that has the potential to stop knee and spine osteoarthritis in its tracks.
Fibromyalgia patients who regularly visit their physicians are much less likely to attempt suicide than those who do not, according to a new Vanderbilt University Medical Center study published in Arthritis Care & Research.
Anyone with arthritis can appreciate how useful it would be if scientists could grow cartilage in the lab. To this end, Keck School of Medicine of USC scientists in the USC Stem Cell laboratory of Denis Evseenko, MD, PhD, collaborated with colleagues at several institutions to provide new insights into how gene activity drives the development of cartilage. Their findings appear today in Nature Communications.
Engineers have developed neutrophil “nanosponges” that can safely absorb and neutralize a variety of proteins that play a role in the progression of rheumatoid arthritis. Injections of these nanosponges effectively treated severe rheumatoid arthritis in two mouse models. Administering the nanosponges early on also prevented the disease from developing. The nanosponges are nanoparticles of biodegradable polymer coated with the cell membranes of neutrophils, a type of white blood cell.
The latest research, features and announcements in healthcare in the Healthcare News Source
A broad coalition of 126 patient and provider groups – led by leading national organizations including the American College of Rheumatology – today sent a letter to the Centers for Medicare and Medicaid Services (CMS) urging the agency not to move forward with a proposal that would significantly reduce Medicare reimbursements for evaluation and management (E/M) services provided by specialists, citing concerns that these time-intensive services – which include examinations, disease diagnosis and risk assessments, and care coordination – are already grossly under-compensated and that additional payment cuts would worsen workforce shortages in already strained specialties like rheumatology.
Researchers from Case Western Reserve University School of Medicine have discovered a way to stop immune cell death associated with multiple diseases, including sepsis, inflammatory bowel disease (IBD), and arthritis. The findings, published in Science Immunology, identify a chemical that potently inhibits inflammatory cell death.
This September, Sports Broadcaster Terry Bradshaw is teaming up once again with the American College of Rheumatology (ACR) to share important information about rheumatic diseases in a new public service announcement (PSA) airing nationwide this fall.
Most Americans will have walked 75,000 miles by the time they reach the age of 50 – the equivalent of trekking around the Earth on the equator three times - which is why regular foot care is so important.
The American College of Rheumatology (ACR) and the Association for Rheumatology Health Professionals (ARHP) welcome members of the press to write about research presented at the 2018 ACR/ARHP Annual Meeting by attending sessions on-site or covering them remotely.
7th DC Metro Autoimmune Walk -- Linking Together for a Cure
Scientists have discovered that in rheumatoid arthritis (RA) patients, lower levels of vitamin D are associated with increased disease severity. Their findings, announced today at the 70th AACC Annual Scientific Meeting & Clinical Lab Expo, indicate that vitamin D supplementation could significantly improve quality of life for RA patients.
Finding could lead to targeted therapies for chronic condition
The American College of Rheumatology expressed concerns that the proposed cuts to cognitive E/M services, along with the methodology changes to PE, will further restrict patient access to rheumatologists and other cognitive specialists at a time when the workforce is already shrinking.
Mary K. Crow, MD, physician-in-chief and chief of Rheumatology, and Jane E. Salmon, MD, rheumatologist at Hospital for Special Surgery (HSS), have been named honorary members of the European League Against Rheumatism (EULAR) during the Annual European Congress of Rheumatology in Amsterdam.
Researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego have found that the cost for the 10 “highest spend” medications in Medicare Part D — the U.S. federal government’s primary prescription drug benefit for older citizens — rose almost one-third between 2011 and 2015, even as the number of persons using these drugs dropped by the same amount.
A recent study by University of Arkansas for Medical Sciences (UAMS) and Central Arkansas Veterans Healthcare System (CAVHS) researchers shows that a type of blood protein we are all born with protects against osteoporosis, illuminating the potential for a novel approach to treatment.
The American College of Rheumatology (ACR) is collaborating with the Emirates Society for Rheumatology (ESR) to co-host their 4th Annual Conference in Dubai, United Arab Emirates, September 19-21, 2018.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right